In our study, we identified elevated SLIT3 expression in a Stage 4S-specific tumor cell subpopulation, suggesting its potential as an auxiliary diagnostic marker for Stage 4S, and an indicator of spontaneous regression. The gene discussed is SLIT3; the disease is neoplasm.